India to Oman: Cladribine Export Trade Route

The India to Oman Cladribine corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $8.5K USD. The route is dominated by DOSHI MEDICARE PRIVATE LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's cladribine manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $2.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with cladribine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #1 among India's top cladribine export destinations globally.

On the import side, key buyers of Indian cladribine in Oman include THE MANAGER. THE MANAGER is the single largest importer with 3 shipments valued at $8.5K USD.

India's cladribine exports to Oman are driven primarily by a handful of large-scale manufacturers. DOSHI MEDICARE PRIVATE LTD with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Oman benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DOSHI MEDICARE PRIVATE LTD — together account for 100% of total trade value on this route. The average shipment value of $2.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, THE MANAGER is the largest importer with 3 shipments worth $8.5K USD — representing 100% of all cladribine imports from India on this route.